Mechanism of Asperosaponin VI Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis

Overview

Journal Chin J Integr Med

Date 2024 Nov 5

PMID 39499411

Authors

Jin-Fang Luo

Yang Yu

Jian-Xin Liu

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the mechanism of action of asperosaponin VI (AVI) in the treatment of rheumatoid arthritis (RA) and validate it in ex vivo experiments using network pharmacology and molecular docking methods.

Methods: The predicted targets of AVI were obtained from PharmMaper, UniProt and SwissTarget Prediction platforms, the disease targets were collected from Online Mendelian Inheritance in Man, Therapeutic Target Database and GeneCards databases, the intersection targets of AVI and RA were obtained from Venny 2.1.0, and the protein-protein interaction (PPI) network was obtained from STRING database, which was analyzed by Cytoscape software and screened to obtain the core targets. Cytoscape software was used to analyze PPI network and screen the core targets. Based on the Database for Annotation, Visualization and Integrated Discovery database, Gene Ontology functional and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed, and Cytoscape software was used to construct the "Disease-Pathway-Target-Drug" network, which was finally verified by molecular docking and animal experiments.

Results: Network pharmacological studies showed that AVI was able to modulate 289 targets, with 102 targets for the potential treatment of RA, with the core pathway being the AKT/PI3K signaling pathway, and the core targets being the epidermal growth factor receptor (EGFR) and matrix metalloproteinase 9 (MMP9). Molecular docking results showed that AVI could produce strong binding with both of the 2 core targets. In vitro cellular experiments showed that AVI reduced nitric oxide, prostaglandin E, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-1 β levels (P<0.05) and inhibited cyclooxygenase-2, nitric oxide synthase, EGFR, MMP9, phosphorylated phosphoinositide 3-kinase (p-PI3K), and phosphorylated serine-threonine kinase (p-AKT) proteins (P<0.05). The results of in vivo studies showed that AVI improved RA score and foot swelling thickness and decreased TNF-α, IL-6, p-PI3K and p-AKT levels in RA rats (P<0.05).

Conclusion: AVI exerts anti-inflammatory and anti-RA effects which might be related to the EGFR/MMP9/AKT/PI3K pathway.

References

Ding D, Zhang Q, Zeng F, Cai M, Gan Y, Dong X . Mechanism of Gentisic Acid on Rheumatoid Arthritis Based on miR-19b-3p/RAF1 Axis. Chin J Integr Med. 2022; 29(6):508-516. DOI: 10.1007/s11655-022-3723-4. View

Huang Y, Xin X, Sultana R, Thumboo J, Fong K . Prevalence and Factors Associated with Concomitant Chinese Medicine Use by Rheumatoid Arthritis Patients in A Multi-Ethnic Asian Population. Chin J Integr Med. 2021; 28(3):223-228. DOI: 10.1007/s11655-021-3494-3. View

Luo J, Zhou H, Lio C . Akebia Saponin D Inhibits the Inflammatory Reaction by Inhibiting the IL-6-STAT3-DNMT3b Axis and Activating the Nrf2 Pathway. Molecules. 2022; 27(19). PMC: 9614599. DOI: 10.3390/molecules27196236. View

Ding X, Li W, Chen D, Zhang C, Wang L, Zhang H . Asperosaponin VI stimulates osteogenic differentiation of rat adipose-derived stem cells. Regen Ther. 2019; 11:17-24. PMC: 6518317. DOI: 10.1016/j.reth.2019.03.007. View

Ardura J, Rackov G, Izquierdo E, Alonso V, Gortazar A, Escribese M . Targeting Macrophages: Friends or Foes in Disease?. Front Pharmacol. 2019; 10:1255. PMC: 6819424. DOI: 10.3389/fphar.2019.01255. View

Luo T, Lu Y, Yan S, Xiao X, Rong X, Guo J . Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective. Chin J Integr Med. 2019; 26(1):72-80. DOI: 10.1007/s11655-019-3064-0. View

Li X, Xie Y, Kang A, Wang Y . New bitongling (NBTL) ameliorates rheumatoid arthritis in rats through inhibiting JAK2/STAT3 signaling pathway. Eur J Histochem. 2021; 65(1). PMC: 7907992. DOI: 10.4081/ejh.2021.3202. View

Tanaka Y . A review of upadacitinib in rheumatoid arthritis. Mod Rheumatol. 2020; 30(5):779-787. DOI: 10.1080/14397595.2020.1782049. View

Kalantar-Zadeh K, Kilpatrick R, Kuwae N, McAllister C, Alcorn Jr H, Kopple J . Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005; 20(9):1880-8. DOI: 10.1093/ndt/gfh941. View

10.

Civico-Ortega J, Gonzalez-Ruiz I, Ramos-Garcia P, Cruz-Granados D, Samayoa-Descamps V, Gonzalez-Moles M . Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Int J Mol Sci. 2023; 24(15). PMC: 10419199. DOI: 10.3390/ijms241511888. View

11.

Hua L, Wang F, Du H, Fan J, Wang Y, Wang L . Upregulation of caspase-3 by high glucose in chondrocyte involves the cytoskeleton aggregation. Eur Rev Med Pharmacol Sci. 2020; 24(11):5925-5932. DOI: 10.26355/eurrev_202006_21485. View

12.

Lee H, Suh Y, Lee S, Cheon Y, Kim M, Noh H . Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity. BMC Res Notes. 2022; 15(1):128. PMC: 8981634. DOI: 10.1186/s13104-022-06008-0. View

13.

Yu G, Huang B, Chen G, Mi Y . Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis. J Thorac Dis. 2015; 7(10):1806-16. PMC: 4635298. DOI: 10.3978/j.issn.2072-1439.2015.10.17. View

14.

Liu Y, Zhang Y, Jia K, Dong Y, Ma W . Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway. Exp Ther Med. 2015; 9(4):1401-1406. PMC: 4353749. DOI: 10.3892/etm.2015.2220. View

15.

Tang H, Qin K, Wang A, Li S, Fang S, Gao W . 3,3'-diindolylmethane inhibits LPS-induced human chondrocytes apoptosis and extracellular matrix degradation by activating PI3K-Akt-mTOR-mediated autophagy. Front Pharmacol. 2022; 13:999851. PMC: 9684728. DOI: 10.3389/fphar.2022.999851. View

16.

Zou Q, Li L, Han Q, Wang Y, Wang X . Abatacept alleviates rheumatoid arthritis development by inhibiting migration of fibroblast-like synoviocytes via MAPK pathway. Eur Rev Med Pharmacol Sci. 2019; 23(7):3105-3111. DOI: 10.26355/eurrev_201904_17594. View

17.

Bang J, Kim G, Park S, Jung H, Kim S, Kim J . GCSB-5 regulates inflammatory arthritis and pain by modulating the mitogen-activated protein kinase signaling pathway in a murine model of rheumatoid arthritis. Arch Rheumatol. 2023; 38(4):566-578. PMC: 10728744. DOI: 10.46497/ArchRheumatol.2023.9643. View

18.

Pan D, Li N, Liu Y, Xu Q, Liu Q, You Y . Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. Int Immunopharmacol. 2017; 55:174-182. DOI: 10.1016/j.intimp.2017.12.011. View

19.

Carlin C . Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections. Front Cell Infect Microbiol. 2022; 11:820355. PMC: 8785968. DOI: 10.3389/fcimb.2021.820355. View

20.

Huang C, Chen H, Chen D, Huang Y, Liu S, Lin Y . Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein. PLoS One. 2017; 12(7):e0180604. PMC: 5507450. DOI: 10.1371/journal.pone.0180604. View